Table 3.

Survey Questions with No Significant Differences Regarding Patients with Active Cancer, History of Cancer, and No History of Cancer (n = 106)

Q1. Do you require a toxicology screen to monitor opioid compliance?

Q3. Does the toxicology screen you employ test only for the opioid you prescribe or does it also include other opioids and illicit drugs?

Q5. For a patient with NO history of substance or chronic opioid use, how frequently do you have the patient complete a toxicology screen to monitor compliance?

Q6. For a patient with a history of substance or chronic opioid use, how frequently do you have the patient complete a toxicology screen to monitor compliance?

Q7. When monitoring a patient's compliance with a toxicology screen, do you schedule it (patient is given advanced notice) or is it random (patient is not given advanced notice)?

Q8. What method do you use to decide when to screen your patient?

Q9. Are patients directly observed as they urinate for the urine toxicology screen?

Q10. Do you require a toxicology screen before every opioid refill?

Q13. For patients who fail a toxicology screen due to nonmedical cannabis use, I (do not refill future prescriptions; discuss importance of urine toxicology screen and prescribe opioid refill; dismiss patient from practice; eliminate opioids from treatment regimen; refer patient to addiction medicine)

Q14. Do you use a psychometric screening tool to risk stratify a patient's potential for opioid abuse?

Q21. Before prescribing opioids, are concerns about treatment side effects, dependence or tolerance discussed with your patients?